About 21st.BIO
21st.BIO is a company based in Virum (Denmark) founded in 2020.. 21st.BIO has raised $152.85 million across 3 funding rounds from investors including Novo Holdings. The company has 38 employees as of November 30, 2024. 21st.BIO offers products and services including Dairy Proteins, Protein Sweeteners, Collagen, Biomaterials, and Agriculture Solutions.
- Headquarter Virum, Denmark
- Employees 38 as on 30 Nov, 2024
- Stage Minicorn
-
Sectors
Consumer
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name 21St.Bio A/S
-
Annual Revenue
-
Net Profit
$-5.19 M (USD)-68as on Dec 31, 2022
-
EBITDA
$-7.68 M (USD)-149as on Dec 31, 2022
-
Total Equity Funding
$152.85 M (USD)
in 3 rounds
-
Latest Funding Round
$21.76 M (USD), Series C
Jun 01, 2023
- Investors
-
Employee Count
38
as on Nov 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of 21st.BIO
21st.BIO offers a comprehensive portfolio of products and services, including Dairy Proteins, Protein Sweeteners, Collagen, Biomaterials, and Agriculture Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Development and scaling of proteins for dairy applications
Optimized sweeteners for food and industrial use
Production of collagen for biomaterials and health sectors
Advanced materials for various industrial applications
Strain development for agricultural biomining processes
Techniques for resource extraction in mining industries
Unlock access to complete
Funding Insights of 21st.BIO
21st.BIO has successfully raised a total of $152.85M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $21.76 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $21.8M
-
First Round
First Round
(17 Dec 2021)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Series C - 21st.BIO | Valuation |
investors |
|
| Sep, 2022 | Amount | Series C - 21st.BIO | Valuation |
investors |
|
| Dec, 2021 | Amount | Series C - 21st.BIO | Valuation | Novo Holdings |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in 21st.BIO
21st.BIO has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Novo Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by 21st.BIO
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - 21st.BIO
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
21St.Bio Comparisons
Competitors of 21st.BIO
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about 21st.BIO
When was 21st.BIO founded?
21st.BIO was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is 21st.BIO located?
21st.BIO is headquartered in Virum, Denmark.
Is 21st.BIO a funded company?
21st.BIO is a funded company, having raised a total of $152.85M across 3 funding rounds to date. The company's 1st funding round was a Series C of $96.9M, raised on Dec 17, 2021.
How many employees does 21st.BIO have?
As of Nov 30, 2024, the latest employee count at 21st.BIO is 38.
What does 21st.BIO do?
21st.BIO was established in 2020 and is based in Virum, Denmark. Market research tailored to the biopharma industry is conducted, with a focus on data analysis and sector insights. Services encompass competitive intelligence, trend forecasting, and strategic advisory support. Operations are directed toward assisting pharmaceutical and biotechnology firms with evidence-based decision-making across global markets.
What products or services does 21st.BIO offer?
21st.BIO offers Dairy Proteins, Protein Sweeteners, Collagen, Biomaterials, and 2 more products and services.
Who are 21st.BIO's investors?
21st.BIO has 1 investor. Key investors include Novo Holdings.
What is 21st.BIO's valuation?
The valuation of 21st.BIO is $91.79M as of Jun 2023.